Skip to main content
Hanshang Group Co.,Ltd. logo

Hanshang Group Co.,Ltd. — Investor Relations & Filings

Ticker · 600774 ISIN · CNE000000NC5 Shanghai Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,577 across all filing types
Latest filing 2020-11-25 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 600774

About Hanshang Group Co.,Ltd.

https://www.whhsg.com/

Hanshang Group Co.,Ltd. is a diversified enterprise focused on commercial operations, exhibition services, and healthcare. The company manages a portfolio of large-scale department stores, shopping malls, and specialized retail outlets. Its exhibition segment provides comprehensive venue management and event organization services for international and domestic trade fairs. Hanshang Group has significantly expanded its presence in the healthcare sector through the development and distribution of pharmaceuticals, medical devices, and health-related products. By integrating traditional commercial assets with modern biomedical research and health management services, the group targets a broad consumer base and professional medical markets, emphasizing a strategic transition toward a comprehensive health-oriented business model.

Recent filings

Filing Released Lang Actions
独立董事关于聘任高管人员的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from independent directors regarding the appointment of a senior executive (vice president) at 汉商集团股份有限公司. It references compliance with regulatory guidelines and company bylaws, and includes signatures of independent directors. The content focuses on management appointment and governance compliance rather than financial results, audit, or shareholder voting results. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes in senior management.
2020-11-25 Chinese
第十届董事会第十八次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolutions passed at the 18th meeting of the 10th Board of Directors of 汉商集团股份有限公司. It includes details about the approval of a borrowing proposal and the appointment of a senior management officer (vice president). The document is a formal announcement of board decisions and management changes, not a full report or financial statement. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused on management appointment and board resolutions, confirming the classification.
2020-11-25 Chinese
关于向银行申请并购借款的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by 汉商集团股份有限公司 regarding the application for a merger and acquisition (M&A) loan from a bank to finance the purchase of 100% shares of 成都迪康药业股份有限公司. It details the loan amount, terms, collateral, board approval, and impact on the company. The document is short (1080 characters) and focuses on financing related to an M&A transaction, specifically a loan application for the acquisition. It is not a full financial report, audit, or earnings release. It is not a report publication announcement or certification. The content fits best under Capital/Financing Update (CAP) as it concerns financing activities related to an M&A transaction, but it is not the M&A announcement itself (which would focus on the transaction details). Therefore, the classification is CAP with high confidence.
2020-11-25 Chinese
关于收到《中国证监会行政许可项目审查一次反馈意见通知书》的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (566 characters) from Han Shang Group regarding receipt of a feedback notice from the China Securities Regulatory Commission (CSRC) about their non-public stock issuance approval process. It states the company will respond and disclose further information in due course. There is no financial data, no full report, and it is clearly an update on a regulatory review process related to capital raising. The document is an announcement about a regulatory matter and not a full report or detailed financial disclosure. Given the short length and nature, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other categories.
2020-11-16 Chinese
关于控股孙公司取得医疗器械经营许可证的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by 汉商集团股份有限公司 regarding its controlling subsidiary obtaining a medical device business license. It includes details about the license, the issuing authority, and the impact on the company. The document is short (1353 characters) and serves as an official notification of a regulatory approval rather than a financial report or detailed management discussion. It does not contain financial data, earnings, or management changes. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-11-12 Chinese
方正证券关于武汉市汉阳控股集团有限公司豁免要约收购汉商集团股份有限公司股份之2020年第三季度持续督导意见
Audit Report / Information Classification · 95% confidence The document is a detailed quarterly supervisory opinion report issued by a financial advisor (方正证券承销保荐有限责任公司) regarding a specific exempted tender offer acquisition involving Wuhan Hanyang Holdings Group Co., Ltd. and Wuhan Hanshang Group Co., Ltd. It references the 2020 third quarter period and discusses compliance with regulatory requirements, governance, transaction progress, and future plans. The document contains substantive content about the acquisition process, governance, and ongoing supervisory opinions rather than just an announcement or summary. It is not a full annual report or earnings release but a specialized supervisory opinion related to an acquisition and regulatory compliance during a quarter. Given the detailed nature and focus on acquisition supervision and compliance, this fits best under the category of Audit Report / Information (AR), which includes results of regulatory or internal stress tests and applied accounting principles related to transactions, excluding full annual reports. The document is not a simple announcement or certification, so it is not RNS or RPA. The length and content confirm it is a report, not a brief notice.
2020-11-12 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.